Maternal outcomes in morbidly adherent placenta: a prospective cohort study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254275Keywords:
Caesarean section, Maternal outcomes, Morbidly adherent placenta, Obstetric haemorrhage, Placenta accreta spectrumAbstract
Background: Morbidly Adherent Placenta (MAP), encompassing placenta accreta, increta, and percreta, is a life-threatening obstetric condition associated with high maternal morbidity and mortality. This study aimed to evaluate maternal outcomes in women diagnosed with MAP and to identify risk factors influencing morbidity and mortality.
Methods: A prospective cohort study was conducted at a Government Medical College and Hospital, Akola, Maharashtra from Oct 2022 to Feb 2024, involving 50 women diagnosed with MAP. Data were collected regarding obstetric history, gestational age at delivery, estimated blood loss, need for hysterectomy, intensive care unit (ICU) stay, duration of hospitalization, and maternal mortality. Statistical analysis was performed to identify associations between previous Caesarean scars, emergency versus planned deliveries, and adverse outcomes.
Results: The majority of patients (62%) had placenta accreta, followed by increta (26%) and percreta (12%). MAP incidence and severity increased with the number of prior caesarean scas. The mean estimated blood loss was 1950±450 mL, and 80% of patients required blood transfusion. Caesarean hysterectomy was performed in 38% of cases. ICU admission was required in 56%, and the average hospital stay was 8.4±2.7 days. Planned deliveries were associated with significantly lower blood loss and fewer complications compared to emergency deliveries.
Conclusions: MAP remains a major cause of maternal morbidity, strongly associated with prior caesarean deliveries. Early antenatal diagnosis, and elective delivery in specialized centres significantly reduce blood loss, operative complications, and mortality.
References
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstetr Gynecol. 2018;218(1):75-87.
Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126(3):654-68.
Bowman ZS, Eller AG, Kennedy AM, Richards DS, Winter TC 3rd, Woodward PJ, et al. Accuracy of ultrasound for the prediction of placenta accreta. Am J Obstet Gynecol. 2014;211(2):177.e1-7.
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458-61.
Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208(3):219.e1-7.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893.
Morel O, van Beekhuizen HJ, Braun T, Collins S, Pateisky P, Calda P, et al. International Society for Placenta Accreta Spectrum (IS-PAS). Performance of antenatal imaging to predict placenta accreta spectrum degree of severity. Acta Obstet Gynecol Scand. 2021;100 Suppl 1(Suppl 1):21-8.
Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274-80.
Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstetr Gynecol. 2006;107(6):1226-32.
Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a Multidisciplinary Care Team compared with standard obstetric care. Obstetr Anesthes Digest. 2012;32(1):41-2.
Einerson BD. Conservative management for placenta accreta spectrum: questions and barriers remain but are surmountable. Am J Obstet Gynecol MFM. 20236;5(3):100859.
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;121(1):62-70.
Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine; Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;219(6):B2-B16.
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20-4.
Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212(5):561-8.
Elkhouly NI, Solyman AE, Anter ME, Sanad ZF, El Ghazaly AN, Ellakwa HE. A new conservative surgical approach for placenta accreta spectrum in a low-resource setting. J Matern Fetal Neonatal Med. 2022;35(16):3076-82.
Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115(1):65-9.
Erfani H, Fox KA, Clark SL, Rac M, Rocky Hui SK, Rezaei A, et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019;221(4):337.e1-337.e5.
BE Porkodi, Suchaita MS, Namratha KN and Dwarakanath L. Optimising fetomaternal outcome in placenta accreta spectrum in previous c-section delivery - A clinical study with review of current guidelines. Int. J. Contraception Gynaecol. Obstet. 2025;7(1):19-25.
Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018;140(3):291-8.
Downloads
Published
How to Cite
Issue
Section
